Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

NCT01352884 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT01352884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01352884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer
Lead sponsor
MedImmune LLC
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2011
Completion date
January 31, 2014
Enrollment
44 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer